Urinary Bladder, Overactive: all 864 studies
Page 1 of 9. Open to participants first (125), then studies with results posted, then the rest; newest registration first within each.
- Parasacral TENS ProjectNot yet recruitingNCT07892417Not applicable
- Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract DysfunctionNot yet recruitingNCT07856238
- Peroneal Neuromodulation vs Pelvic Floor Exercises in OABNot yet recruitingNCT07788560Not applicable
- Impact of Transcutaneous Electrical Nerve Stimulation on the Autonomic Nervous System in the Treatment of Overactive BladderNot yet recruitingNCT07781033Not applicable
- Non-invasive Saphenous Nerve Stimulation Therapy for Overactive BladderNot yet recruitingNCT07780786Phase 3
- Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive BladderNot yet recruitingNCT07773532
- Transcranial Direct Current Stimulation for Neurogenic Overactive Bladder Symptoms Among People With StrokeNot yet recruitingNCT07768137Not applicable
- Treatment Efficacy for Overactive Bladder: Comparing Education, Biofeedback, and Nerve StimulationNot yet recruitingNCT07744620Not applicable
- Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After StrokeNot yet recruitingNCT07740668Not applicable
- Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety?RecruitingNCT07740629Not applicable
- Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in WomenNot yet recruitingNCT07739550Not applicable
- Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled StudyNot yet recruitingNCT07711808Phase 4
- Pretibial TENS for Pain and Anxiety During Intravesical OnabotulinumtoxinA InjectionNot yet recruitingNCT07707791Not applicable
- Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation TherapyRecruitingNCT07662824Not applicable
- Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsRecruitingNCT07648290Early Phase 1
- A Novel Wearable Transcutaneous Tibial Nerve Stimulation (TTNS) Device in the Treatment of Patients With Overactive Bladder (OAB) and NocturiaNot yet recruitingNCT07635251Not applicable
- Efficacy of Probiotics for OAB Patients With AnxietyNot yet recruitingNCT07635212Not applicable
- Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson DiseaseNot yet recruitingNCT07627529Phase 4
- The Effectiveness of Transcutaneous Sacral Neuromodulation Techniques-Magnetic Stimulation and Electrical Stimulation-on Detrusor Overactivity in Patients With Spinal Cord InjuryRecruitingNCT07578532Not applicable
- Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic SyndromeRecruitingNCT07563764Not applicable
- RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive BladderRecruitingNCT07553065Phase 2
- Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of LifeNot yet recruitingNCT07545148
- Effectiveness of Ambulatory Transcutaneous Tibial Nerve Stimulation for Overactive BladderRecruitingNCT07540273Not applicable
- The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D DeficiencyNot yet recruitingNCT07513363Not applicable
- Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in WomenRecruitingNCT07473310Phase 4
- The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive BladderEnrolling by invitationNCT07463326Not applicable
- Turkish USIQ: Validity & ReliabilityNot yet recruitingNCT07452796
- Add-On ZIDA Sock Therapy for Overactive BladderRecruitingNCT07432659Not applicable
- Efficacy of Gabapentin Combined With Solifenacin for Non-neurogenic Overactive Bladder in WomenNot yet recruitingNCT07429734Phase 3
- Ambulatory Long Length URodynamics EvaluationRecruitingNCT07425015Not applicable
- Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National StudyRecruitingNCT07416968Phase 4
- Zinc Supplementation With Botulinum Toxin for Overactive BladderRecruitingNCT07405554Phase 2
- Evaluate the Safety and Efficacy of TRG-200 KIT in Patients With Refractory Overactive Bladder.Not yet recruitingNCT07391878Phase 2
- A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox InjectionsNot yet recruitingNCT07387315Phase 4
- Bladder Overactivity and Post-Botulinum Toxin TelemonitoringNot yet recruitingNCT07379372Not applicable
- Early Detection of OAB and Elimination of Negative Impact on Quality of LifeRecruitingNCT07371000Not applicable
- Comparison of the Efficacy of Perineal and Intravaginal Electrical Stimulation in Women With Idiopathic Overactive BladderRecruitingNCT07366918Not applicable
- Urinary Function and Multimorbidity Risks: A Longitudinal Study in Beijing Community-Dwelling ElderlyNot yet recruitingNCT07357714
- Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord InjuryRecruitingNCT07343583Not applicable
- Aquarius Pilot Study to Evaluate the New Axonics Trial SystemRecruitingNCT07335484Not applicable
- Mirabegron in Patients With Age-Related Macular DegenerationNot yet recruitingNCT07305298
- Tensi+ for Treating Overactive BladderRecruitingNCT07300904Not applicable
- Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive BladderNot yet recruitingNCT07279142Not applicable
- Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene TherapyNot yet recruitingNCT07227285Phase 1/2
- Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in WomenRecruitingNCT07209397Not applicable
- Tensi+ European Post-Market Clinical Follow-UpRecruitingNCT07205445
- Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)RecruitingNCT07195656Not applicable
- Sexual Dysfunction in Women With Multiple Sclerosis (MS)RecruitingNCT07193823
- INOPASE - Performance and Safety Study of a Personalised SNM SystemRecruitingNCT07193407Not applicable
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson DiseaseNot yet recruitingNCT07187466Phase 4
- Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized TrialRecruitingNCT07184307Not applicable
- At-Home Transcutaneous Tibial Nerve Stimulation for Overactive Bladder in Rural WomenRecruitingNCT07178314Not applicable
- Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss TherapyNot yet recruitingNCT07175805
- The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled TrialNot yet recruitingNCT07114640Phase 3
- Home-Based Transcutaneous Remotely Monitored Posterior Tibial NeuromodulationRecruitingNCT07081412Not applicable
- Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous NeurostimulationRecruitingNCT07030803Not applicable
- Comparing Treatments for Overactive Bladder in Taiwan: A Study of OutcomesRecruitingNCT07025642Not applicable
- Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor InjectionsRecruitingNCT07025044
- Predictive Utility and Mechanisms of Sacral Evoked Responses in Sacral NeuromodulationRecruitingNCT06983470Not applicable
- Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA InjectionRecruitingNCT06953271Phase 4
- Investigation of Effects of Electrical Stimulation in Women With Vaginal LaxityRecruitingNCT06935240Not applicable
- Elastographic Assessment of Suburethral Tissue in Continent and Incontinent WomenRecruitingNCT06933407
- Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female PatientsRecruitingNCT06921746
- APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in WomenRecruitingNCT06797245Not applicable
- PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OABRecruitingNCT06789406Not applicable
- Effect of Neuromodulation and Therapeutic Exercise in Urinary IncontinenceRecruitingNCT06783374Not applicable
- Overactive Bladder Syndrome and Hypopressive ExerciseEnrolling by invitationNCT06780657Not applicable
- Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in ChildrenNot yet recruitingNCT06769854Phase 4
- Transcutaneous Tibial Nerve Stimulation Therapy in Children With Overactive BladderEnrolling by invitationNCT06765629Not applicable
- Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a InjectionsNot yet recruitingNCT06695585Phase 4
- Effect of Pelvic Floor Down-training on Women With Idiopathic Overactive BladderNot yet recruitingNCT06662565Not applicable
- Cefar URO - Symptomatic Treatment of Overactive BladderRecruitingNCT06659536Not applicable
- Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome and Associated Gait Changes in Post-menopausal WomenNot yet recruitingNCT06617676Not applicable
- Enhancing Pelvic Floor Function With Transcranial Magnetic and Tibial Nerve Stimulation for Neurogenic Bladder in MSNot yet recruitingNCT06581341Not applicable
- Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control StudyEnrolling by invitationNCT06563193
- Tibial Nerve Stimulation for Post-BPH Overactive BladderNot yet recruitingNCT06558539Phase 3
- Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)RecruitingNCT06551246Phase 3
- NeuroGyn Genital Neuromodulation System for iOAB TreatmentNot yet recruitingNCT06529198Not applicable
- Sacral Neuromodulation for Male Overactive Bladder (MOAB)RecruitingNCT06511141Not applicable
- Optimal Injection Interval for Intra-Detrusor Botulinum ToxinNot yet recruitingNCT06483217Not applicable
- Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive BladderRecruitingNCT06479720Phase 4
- Evaluation of Efficacy and Patient Satisfaction of Local Anaesthesia Versus Sedoanalgesia for Botox (R) Injection in the Urinary Bladder for the Treatment of Idiopathic Overactive BladderEnrolling by invitationNCT06437899Not applicable
- Evaluation of Autonomic Nervous System Changes in Response to Stimulation by Sacral NeuromodulationRecruitingNCT06434831Not applicable
- Transcutaneous Medial Plantar Nerve Stimulation in Women With Idiopathic Overactive BladderNot yet recruitingNCT06390488Not applicable
- Bladder Botox UTI Antibiotic ProphylaxisRecruitingNCT06387329Phase 4
- Transcutaneous Tibial Nerve Stimulation in Patients With Neurogenic Overactive Bladder After StrokeNot yet recruitingNCT06385769Not applicable
- Comparison of the Efficacy of Transcutaneos Nerve Stimulations in Women With Idiopathic Overactive BladderNot yet recruitingNCT06349694Not applicable
- Impact of TTNS on Bladder Symptoms Among People With MS, A RCTRecruitingNCT06341673Not applicable
- Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive BladderEnrolling by invitationNCT06283498Not applicable
- Percutaneous Nerve Evaluation Trial TimeRecruitingNCT06226220Not applicable
- Migraine Medication Effects on Urinary SymptomsEnrolling by invitationNCT06212661
- Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABSRecruitingNCT06209333Not applicable
- Vitamin D Treat-to-Target Strategy for Children With Overactive Bladder-WetRecruitingNCT06201013Not applicable
- Efficacy of Combined Pharmacotherapy Versus Solifenacin With Vaginal Estrogen Cream for Women With Detrusor OveractivityRecruitingNCT06197295Phase 4
- A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB)Not yet recruitingNCT06181591Phase 2
- Effectiveness of Oral Boldo in Women With Overactive BladderEnrolling by invitationNCT06162065Phase 1
- Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive BladderRecruitingNCT06088394Not applicable
- Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MSRecruitingNCT06072703Not applicable
- Comparison of a Paper and Automated Bladder Diary in Pediatric PatientsRecruitingNCT06070675Not applicable
- Clinical Efficacy Evaluation of Electroacupuncture as Adjuvant Therapy for Female Patients With Overactive BladderRecruitingNCT05997992Not applicable